- Second-quarter 2026 sales of $2.8 billion, up 8% on a reported basis, or up 7%
constant currency1
(cc), versus second-quarter 2025 - Returned $538 million to shareholders through dividends and share repurchases
on a year-to-date basis - Updated full-year guidance – raised core operating margin and core diluted EPS
growth
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, August 10, 2026 – Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial
results for the three and six month periods ending June 30, 2026. For the second quarter of 2026, sales
were $2.8 billion, up 8% on a reported basis and up 7% on a constant currency basis1, as compared to
the same quarter of the previous year. Alcon reported diluted earnings per share of $0.00 and core
diluted earnings per share2 of $0.84 in the second quarter of 2026.
“Our team delivered strong second-quarter results and executed well across the business,” said David
J. Endicott, Alcon’s Chief Executive Officer. “UNITY, PanOptix Pro, TRYPTYR and other recent launches
are driving growth and reinforcing the strength of our innovation engine. Across the portfolio, our
innovative products continue to gain traction and expand our market positions, including contact
lenses where we are continuing to gain share. With a robust pipeline and several important launches
ahead, we are well positioned to deliver sustainable long-term growth and further strengthen our
leadership in eye care.”
Second-quarter and first-half 2026 key figures and more detailed reports please click the link below. https://www.alcon.com/media-release/new-product-launches-and-strong-commercial-execution-drive-alcons-second-quarter-2026/
- Digital Sponsors -
